Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Synlogic, Inc.
Synlogic Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports First Quarter 2024 Financial Results
May 14, 2024
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results
March 19, 2024
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Adopts Limited Duration Stockholders Rights Plan
February 20, 2024
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
February 08, 2024
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria
February 02, 2024
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Provides Corporate Update and Outlook for 2024
January 04, 2024
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Contract with the Air Force Research Lab
December 27, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023
December 07, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 09, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration
November 07, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Closing of $21.0 Million Underwritten Public Offering
October 03, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
September 29, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism
September 28, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Reverse Stock Split
September 27, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic to Participate in Chardan’s Genetic Medicines Conference
September 21, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100
September 19, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria
July 11, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces International Nonproprietary Name Selection for SYNB1934
June 28, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum
June 27, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reminds Stockholders of 2023 Annual General Meeting Details
June 08, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
June 05, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
May 24, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic to Present at the Jefferies Global Healthcare Conference
May 23, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of Phenylketonuria
May 09, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
March 29, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of Phenylketonuria
March 28, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
March 20, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.